vs
CENTERSPACE（CSR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是CENTERSPACE的1.0倍（$69.8M vs $66.6M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -27.7%，领先411.7%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 0.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 1.6%）
Centerspace是一家专注于多户住宅物业持有、运营与开发的房地产投资企业，核心业务覆盖美国中西部及落基山西部区域，面向不同租户群体提供经济型及高端住宅选择，重视租户体验与资产长期价值增长。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CSR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$66.6M
营收增速更快
RIGL
高出20.9%
0.3%
净利率更高
RIGL
高出411.7%
-27.7%
两年增速更快
RIGL
近两年复合增速
1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.6M | $69.8M |
| 净利润 | $-18.4M | $268.1M |
| 毛利率 | 96.5% | 91.5% |
| 营业利润率 | -15.9% | 33.2% |
| 净利率 | -27.7% | 384.0% |
| 营收同比 | 0.3% | 21.2% |
| 净利润同比 | -262.9% | 1769.2% |
| 每股收益（稀释后） | $-1.08 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSRRIGL
| Q4 25 | $66.6M | $69.8M | ||
| Q3 25 | $71.4M | $69.5M | ||
| Q2 25 | $68.5M | $101.7M | ||
| Q1 25 | $67.1M | $53.3M | ||
| Q4 24 | $66.4M | $57.6M | ||
| Q3 24 | $65.0M | $55.3M | ||
| Q2 24 | $65.0M | $36.8M | ||
| Q1 24 | $64.5M | $29.5M |
净利润CSRRIGL
| Q4 25 | $-18.4M | $268.1M | ||
| Q3 25 | $53.8M | $27.9M | ||
| Q2 25 | $-14.5M | $59.6M | ||
| Q1 25 | $-3.7M | $11.4M | ||
| Q4 24 | $-5.1M | $14.3M | ||
| Q3 24 | $-1.0M | $12.4M | ||
| Q2 24 | $-1.3M | $-1.0M | ||
| Q1 24 | $-3.9M | $-8.2M |
毛利率CSRRIGL
| Q4 25 | 96.5% | 91.5% | ||
| Q3 25 | 96.5% | 93.2% | ||
| Q2 25 | 96.5% | 95.6% | ||
| Q1 25 | 96.4% | 91.7% | ||
| Q4 24 | 96.5% | 89.9% | ||
| Q3 24 | 96.6% | 85.5% | ||
| Q2 24 | 96.6% | 92.4% | ||
| Q1 24 | 96.4% | 93.1% |
营业利润率CSRRIGL
| Q4 25 | -15.9% | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | -9.9% | 60.1% | ||
| Q1 25 | 7.1% | 23.9% | ||
| Q4 24 | 4.3% | 28.9% | ||
| Q3 24 | 9.8% | 25.4% | ||
| Q2 24 | 11.1% | 1.2% | ||
| Q1 24 | 6.3% | -23.6% |
净利率CSRRIGL
| Q4 25 | -27.7% | 384.0% | ||
| Q3 25 | 75.3% | 40.2% | ||
| Q2 25 | -21.2% | 58.6% | ||
| Q1 25 | -5.6% | 21.5% | ||
| Q4 24 | -7.6% | 24.9% | ||
| Q3 24 | -1.6% | 22.5% | ||
| Q2 24 | -2.0% | -2.8% | ||
| Q1 24 | -6.1% | -27.9% |
每股收益（稀释后）CSRRIGL
| Q4 25 | $-1.08 | $14.11 | ||
| Q3 25 | $3.19 | $1.46 | ||
| Q2 25 | $-0.87 | $3.28 | ||
| Q1 25 | $-0.22 | $0.63 | ||
| Q4 24 | $-0.31 | $0.82 | ||
| Q3 24 | $-0.40 | $0.70 | ||
| Q2 24 | $-0.19 | $-0.06 | ||
| Q1 24 | $-0.37 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.8M | $155.0M |
| 总债务越低越好 | $1.0B | $52.5M |
| 股东权益账面价值 | $719.2M | $391.5M |
| 总资产 | $1.9B | $513.6M |
| 负债/权益比越低杠杆越低 | 1.42× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CSRRIGL
| Q4 25 | $12.8M | $155.0M | ||
| Q3 25 | $12.9M | $137.1M | ||
| Q2 25 | $12.4M | $108.4M | ||
| Q1 25 | $11.9M | $77.1M | ||
| Q4 24 | $12.0M | $77.3M | ||
| Q3 24 | $14.5M | $61.1M | ||
| Q2 24 | $14.3M | $49.1M | ||
| Q1 24 | $12.7M | $49.5M |
总债务CSRRIGL
| Q4 25 | $1.0B | $52.5M | ||
| Q3 25 | $1.1B | $60.0M | ||
| Q2 25 | $1.1B | $60.0M | ||
| Q1 25 | $955.5M | $60.0M | ||
| Q4 24 | $955.4M | $60.0M | ||
| Q3 24 | $921.3M | $60.0M | ||
| Q2 24 | $931.7M | $60.0M | ||
| Q1 24 | $929.1M | $60.0M |
股东权益CSRRIGL
| Q4 25 | $719.2M | $391.5M | ||
| Q3 25 | $748.6M | $117.6M | ||
| Q2 25 | $710.1M | $81.9M | ||
| Q1 25 | $636.8M | $18.6M | ||
| Q4 24 | $752.0M | $3.3M | ||
| Q3 24 | $672.5M | $-14.6M | ||
| Q2 24 | $680.7M | $-29.9M | ||
| Q1 24 | $688.1M | $-31.7M |
总资产CSRRIGL
| Q4 25 | $1.9B | $513.6M | ||
| Q3 25 | $2.1B | $242.5M | ||
| Q2 25 | $2.0B | $206.7M | ||
| Q1 25 | $1.9B | $176.0M | ||
| Q4 24 | $1.9B | $164.0M | ||
| Q3 24 | $1.9B | $139.4M | ||
| Q2 24 | $1.9B | $128.4M | ||
| Q1 24 | $1.9B | $126.5M |
负债/权益比CSRRIGL
| Q4 25 | 1.42× | 0.13× | ||
| Q3 25 | 1.53× | 0.51× | ||
| Q2 25 | 1.57× | 0.73× | ||
| Q1 25 | 1.50× | 3.23× | ||
| Q4 24 | 1.27× | 18.25× | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 1.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $64.3M | — |
| 自由现金流率自由现金流/营收 | 96.5% | — |
| 资本支出强度资本支出/营收 | 51.3% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $125.9M | — |
8季度趋势，按日历期对齐
经营现金流CSRRIGL
| Q4 25 | $98.5M | $22.0M | ||
| Q3 25 | $35.1M | $24.0M | ||
| Q2 25 | $25.3M | $30.5M | ||
| Q1 25 | $25.4M | $-893.0K | ||
| Q4 24 | $98.2M | $14.5M | ||
| Q3 24 | $32.3M | $21.7M | ||
| Q2 24 | $22.9M | $302.0K | ||
| Q1 24 | $24.4M | $-5.0M |
自由现金流CSRRIGL
| Q4 25 | $64.3M | — | ||
| Q3 25 | $25.7M | — | ||
| Q2 25 | $15.5M | — | ||
| Q1 25 | $20.4M | — | ||
| Q4 24 | $41.6M | — | ||
| Q3 24 | $20.5M | — | ||
| Q2 24 | $9.1M | — | ||
| Q1 24 | $2.6M | — |
自由现金流率CSRRIGL
| Q4 25 | 96.5% | — | ||
| Q3 25 | 36.0% | — | ||
| Q2 25 | 22.7% | — | ||
| Q1 25 | 30.4% | — | ||
| Q4 24 | 62.6% | — | ||
| Q3 24 | 31.5% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 4.0% | — |
资本支出强度CSRRIGL
| Q4 25 | 51.3% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 14.2% | — | ||
| Q1 25 | 7.5% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 18.2% | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 33.8% | — |
现金转化率CSRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 0.65× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSR
| Multi Family Residential | $57.3M | 86% |
| Other | $8.1M | 12% |
| Other Property Revenue | $1.2M | 2% |
RIGL
暂无分部数据
